Teladoc Health, Inc. (NYSE:TDOC) Short Interest Down 13.5% in December

Teladoc Health, Inc. (NYSE:TDOC) was the target of a significant decrease in short interest during the month of December. As of December 15th, there was short interest totalling 22,710,000 shares, a decrease of 13.5% from the November 30th total of 26,240,000 shares. Based on an average trading volume of 5,360,000 shares, the days-to-cover ratio is presently 4.2 days.

Teladoc Health Stock Performance

Teladoc Health stock opened at $9.45 on Monday. Teladoc Health has a 1-year low of $6.76 and a 1-year high of $22.54. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $1.63 billion, a PE ratio of -1.64 and a beta of 0.97. The firm’s 50 day simple moving average is $9.84 and its 200 day simple moving average is $9.06.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.10. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The firm had revenue of $640.51 million for the quarter, compared to analysts’ expectations of $630.50 million. As a group, analysts expect that Teladoc Health will post -1.16 earnings per share for the current fiscal year.

Analyst Ratings Changes

TDOC has been the topic of a number of recent research reports. Piper Sandler reiterated an “overweight” rating and issued a $13.00 target price (up from $11.00) on shares of Teladoc Health in a report on Wednesday, December 4th. Barclays lifted their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a report on Thursday, October 31st. The Goldman Sachs Group assumed coverage on Teladoc Health in a research note on Friday, November 15th. They set a “buy” rating and a $14.00 price target for the company. Royal Bank of Canada boosted their price objective on Teladoc Health from $9.00 to $10.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 9th. Finally, TD Cowen cut their price target on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Thursday, October 31st. Fourteen analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $12.24.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total value of $28,500.77. Following the transaction, the insider now directly owns 2,890 shares of the company’s stock, valued at approximately $34,477.70. The trade was a 45.25 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.95% of the company’s stock.

Institutional Trading of Teladoc Health

Hedge funds have recently added to or reduced their stakes in the business. Signaturefd LLC increased its holdings in shares of Teladoc Health by 148.7% in the second quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock worth $28,000 after buying an additional 1,715 shares during the period. International Assets Investment Management LLC bought a new stake in Teladoc Health in the 2nd quarter worth $29,000. Blue Trust Inc. increased its holdings in Teladoc Health by 84.5% during the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock valued at $40,000 after purchasing an additional 1,854 shares during the period. Doheny Asset Management CA bought a new position in shares of Teladoc Health during the second quarter valued at approximately $46,000. Finally, Benjamin F. Edwards & Company Inc. lifted its position in shares of Teladoc Health by 209.8% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 5,015 shares of the health services provider’s stock worth $49,000 after purchasing an additional 3,396 shares during the period. 76.82% of the stock is owned by institutional investors.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.